News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
768,620 Results
Type
Article (54855)
Company Profile (379)
Press Release (713373)
Multimedia
Podcasts (131)
Webinars (20)
Section
Business (214600)
Career Advice (2161)
Deals (37210)
Drug Delivery (132)
Drug Development (86597)
Employer Resources (177)
FDA (17286)
Job Trends (15760)
News (365337)
Policy (35233)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2812)
Academic (1)
Accelerated approval (36)
Adcomms (32)
Allergies (152)
Alliances (52910)
ALS (178)
Alzheimer's disease (1729)
Antibody-drug conjugate (ADC) (356)
Approvals (17527)
Artificial intelligence (568)
Autoimmune disease (168)
Automation (43)
Bankruptcy (377)
Best Places to Work (11977)
BIOSECURE Act (21)
Biosimilars (202)
Biotechnology (236)
Bladder cancer (168)
Brain cancer (65)
Breast cancer (688)
Cancer (5199)
Cardiovascular disease (432)
Career advice (1835)
Career pathing (37)
CAR-T (303)
CDC (55)
Celiac Disease (2)
Cell therapy (795)
Cervical cancer (39)
Clinical research (73595)
Collaboration (1830)
Company closure (4)
Compensation (1192)
Complete response letters (71)
COVID-19 (2885)
CRISPR (102)
C-suite (909)
Cystic fibrosis (150)
Data (6436)
Decentralized trials (2)
Denatured (40)
Depression (139)
Diabetes (522)
Diagnostics (7032)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (275)
Drug pricing (207)
Drug shortages (31)
Duchenne muscular dystrophy (237)
Earnings (92817)
Editorial (64)
Employer branding (21)
Employer resources (156)
Events (123614)
Executive appointments (1025)
FDA (20516)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1536)
Gene editing (213)
Generative AI (48)
Gene therapy (634)
GLP-1 (1042)
Government (5011)
Grass and pollen (7)
Guidances (385)
Healthcare (19706)
HIV (66)
Huntington's disease (46)
IgA nephropathy (86)
Immunology and inflammation (277)
Immuno-oncology (69)
Indications (122)
Infectious disease (3181)
Inflammatory bowel disease (206)
Inflation Reduction Act (15)
Influenza (123)
Intellectual property (262)
Interviews (336)
IPO (17133)
IRA (57)
Job creations (4129)
Job search strategy (1533)
JPM (66)
Kidney cancer (17)
Labor market (86)
Layoffs (604)
Leadership (36)
Legal (8666)
Liver cancer (99)
Longevity (16)
Lung cancer (706)
Lymphoma (390)
Machine learning (44)
Management (61)
Manufacturing (848)
MASH (172)
Medical device (14070)
Medtech (14129)
Mergers & acquisitions (21162)
Metabolic disorders (1337)
Multiple sclerosis (167)
NASH (17)
Neurodegenerative disease (336)
Neuropsychiatric disorders (93)
Neuroscience (3020)
Neurotech (1)
NextGen: Class of 2026 (6884)
Non-profit (4794)
Now hiring (68)
Obesity (629)
Opinion (305)
Ovarian cancer (172)
Pain (220)
Pancreatic cancer (245)
Parkinson's disease (290)
Partnered (34)
Patents (525)
Patient recruitment (515)
Peanut (61)
People (62036)
Pharmaceutical (95)
Pharmacy benefit managers (32)
Phase 1 (22873)
Phase 2 (32189)
Phase 3 (24175)
Pipeline (5599)
Policy (314)
Postmarket research (2969)
Preclinical (9899)
Press Release (68)
Prostate cancer (257)
Psychedelics (54)
Radiopharmaceuticals (304)
Rare diseases (903)
Real estate (6425)
Recruiting (72)
Regulatory (26246)
Reports (53)
Research institute (2593)
Resumes & cover letters (367)
Rett syndrome (27)
RNA editing (19)
RSV (87)
Schizophrenia (161)
Series A (251)
Series B (197)
Service/supplier (11)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (161)
Sponsored (45)
Startups (3889)
State (2)
Stomach cancer (21)
Supply chain (108)
Tariffs (97)
The Weekly (89)
Vaccines (1122)
Venture capital (94)
Weight loss (420)
Women's health (97)
Worklife (18)
Date
Today (158)
Last 7 days (703)
Last 30 days (2448)
Last 365 days (30939)
2026 (4288)
2025 (31253)
2024 (36452)
2023 (41351)
2022 (52670)
2021 (57248)
2020 (55778)
2019 (48591)
2018 (36788)
2017 (34132)
2016 (33843)
2015 (39745)
2014 (33706)
2013 (29119)
2012 (31264)
2011 (31925)
2010 (30263)
Location
Africa (861)
Alabama (85)
Alaska (7)
Arizona (326)
Arkansas (15)
Asia (44204)
Australia (7273)
California (11637)
Canada (3366)
China (1169)
Colorado (490)
Connecticut (493)
Delaware (346)
Europe (96803)
Florida (1735)
Georgia (364)
Hawaii (3)
Idaho (62)
Illinois (903)
India (73)
Indiana (543)
Iowa (22)
Japan (448)
Kansas (130)
Kentucky (42)
Louisiana (26)
Maine (72)
Maryland (1437)
Massachusetts (8393)
Michigan (332)
Minnesota (647)
Mississippi (5)
Missouri (133)
Montana (35)
Nebraska (28)
Nevada (127)
New Hampshire (79)
New Jersey (3104)
New Mexico (31)
New York (3071)
North Carolina (1525)
North Dakota (8)
Northern California (5672)
Ohio (343)
Oklahoma (22)
Oregon (49)
Pennsylvania (2347)
Puerto Rico (25)
Rhode Island (48)
South America (1228)
South Carolina (70)
South Dakota (1)
Southern California (4529)
Tennessee (179)
Texas (1790)
United States (41425)
Utah (347)
Vermont (1)
Virginia (283)
Washington D.C. (81)
Washington State (963)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
768,620 Results for "cancer prevention pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026
January 7, 2026
·
3 min read
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
Press Releases
Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value
February 1, 2026
·
5 min read
Press Releases
/C O R R E C T I O N -- BLOOD CANCER UNITED, INC./
February 17, 2026
·
3 min read
Press Releases
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
February 19, 2026
·
13 min read
Press Releases
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
February 18, 2026
·
8 min read
Press Releases
MyOme Launches First Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection and Personalized Prevention
November 21, 2025
·
5 min read
Press Releases
PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
February 5, 2026
·
4 min read
Press Releases
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers
February 20, 2026
·
12 min read
Press Releases
Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models
February 17, 2026
·
5 min read
1 of 76,862
Next